» Articles » PMID: 39117613

AI Hybrid Survival Assessment for Advanced Heart Failure Patients with Renal Dysfunction

Overview
Journal Nat Commun
Specialty Biology
Date 2024 Aug 8
PMID 39117613
Authors
Affiliations
Soon will be listed here.
Abstract

Renal dysfunction (RD) often characterizes the worse course of patients with advanced heart failure (AHF). Many prognosis assessments are hindered by researcher biases, redundant predictors, and lack of clinical applicability. In this study, we enroll 1736 AHF/RD patients, including data from Henan Province Clinical Research Center for Cardiovascular Diseases (which encompasses 11 hospital subcenters), and Beth Israel Deaconess Medical Center. We developed an AI hybrid modeling framework, assembling 12 learners with different feature selection paradigms to expand modeling schemes. The optimized strategy is identified from 132 potential schemes to establish an explainable survival assessment system: AIHFLevel. The conditional inference survival tree determines a probability threshold for prognostic stratification. The evaluation confirmed the system's robustness in discrimination, calibration, generalization, and clinical implications. AIHFLevel outperforms existing models, clinical features, and biomarkers. We also launch an open and user-friendly website www.hf-ai-survival.com , empowering healthcare professionals with enhanced tools for continuous risk monitoring and precise risk profiling.

Citing Articles

Association of platelet-to-lymphocyte ratio with 1-year all-cause mortality in ICU patients with heart failure.

Hu X, Cheng S, Du H, Yin Y Sci Rep. 2024; 14(1):32016.

PMID: 39738748 PMC: 11686032. DOI: 10.1038/s41598-024-83583-1.

References
1.
Tsutsui H, Albert N, Coats A, Anker S, Bayes-Genis A, Butler J . Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. Eur J Heart Fail. 2023; 25(5):616-631. DOI: 10.1002/ejhf.2848. View

2.
Chen L, Liu R, Liu Z, Li M, Aihara K . Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep. 2012; 2:342. PMC: 3314989. DOI: 10.1038/srep00342. View

3.
Lietz K, Long J, Kfoury A, Slaughter M, Silver M, Milano C . Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007; 116(5):497-505. DOI: 10.1161/CIRCULATIONAHA.107.691972. View

4.
Bommert A, Welchowski T, Schmid M, Rahnenfuhrer J . Benchmark of filter methods for feature selection in high-dimensional gene expression survival data. Brief Bioinform. 2021; 23(1). PMC: 8769710. DOI: 10.1093/bib/bbab354. View

5.
Wang F, Kaushal R, Khullar D . Should Health Care Demand Interpretable Artificial Intelligence or Accept "Black Box" Medicine?. Ann Intern Med. 2019; 172(1):59-60. DOI: 10.7326/M19-2548. View